We have shown previously that TGF-β signaling, which is implicated in aging processes in other lung diseases (54, 55), leads to a decrease in ASL volume, and pirfenidone, a therapy for IPF, can restore ASL volume (56). Here, TGFB1 is linked to lung disorder.